TSHA
Taysha Gene Therapies Inc.
$4.46
-$0.50(-10.08%)
55
Overall
60
Value
63
Tech
42
Quality
Market Cap
$1.36B
Volume
9.20M
52W Range
$1.05 - $5.51
Target Price
$9.77
Key Metrics Overview
| Market Cap | $1.36B | P/E Ratio | N/A |
| 52W High | $5.51 | 52W Low | $1.05 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 57.4% | 52W Position | 76.5% |
| Overall Score | 55 | Value Score | 60 |
| Quality Score | 42 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-0.35 | EPS Next Est | $-0.4 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $4.46 | -10.1% | 9.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW